Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), given each month during the transmission season, is recommended for children living in areas of the Sahel where malaria transmission is highly seasonal. The recommendation for SMC is currently limited to children under five years of age, but, in many areas of seasonal transmission, the burden in older children may justify extending this age limit. This study was done to determine the effectiveness of SMC in Senegalese children up to ten years of age. METHODS AND FINDINGS: SMC was introduced into three districts over three years in central Senegal using a stepped-wedge cluster-randomised design. A census of the population was undertaken and a surveillance system was established to record all deaths and to record all cases of malaria seen at health facilities. A pharmacovigilance system was put in place to detect adverse drug reactions. Fifty-four health posts were randomised. Nine started implementation of SMC in 2008, 18 in 2009, and a further 18 in 2010, with 9 remaining as controls. In the first year of implementation, SMC was delivered to children aged 3-59 months; the age range was then extended for the latter two years of the study to include children up to 10 years of age. Cluster sample surveys at the end of each transmission season were done to measure coverage of SMC and the prevalence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure insecticide-treated net (ITN) use. Entomological monitoring and assessment of costs of delivery in each health post and of community attitudes to SMC were also undertaken. About 780,000 treatments were administered over three years. Coverage exceeded 80% each month. Mortality, the primary endpoint, was similar in SMC and control areas (4.6 and 4.5 per 1000 respectively in children under 5 years and 1.3 and 1.2 per 1000 in children 5-9 years of age; the overall mortality rate ratio [SMC: no SMC] was 0.90, 95% CI 0.68-1.2, p = 0.496). A reduction of 60% (95% CI 54%-64%, p < 0.001) in the incidence of malaria cases confirmed by a rapid diagnostic test (RDT) and a reduction of 69% (95% CI 65%-72%, p < 0.001) in the number of treatments for malaria (confirmed and unconfirmed) was observed in children. In areas where SMC was implemented, incidence of confirmed malaria in adults and in children too old to receive SMC was reduced by 26% (95% CI 18%-33%, p < 0.001) and the total number of treatments for malaria (confirmed and unconfirmed) in these older age groups was reduced by 29% (95% CI 21%-35%, p < 0.001). One hundred and twenty-three children were admitted to hospital with a diagnosis of severe malaria, with 64 in control areas and 59 in SMC areas, showing a reduction in the incidence rate of severe disease of 45% (95% CI 5%-68%, p = 0.031). Estimates of the reduction in the prevalence of parasitaemia at the end of the transmission season in SMC areas were 68% (95% CI 35%-85%) p = 0.002 in 2008, 84% (95% CI 58%-94%, p < 0.001) in 2009, and 30% (95% CI -130%-79%, p = 0.56) in 2010. SMC was well tolerated with no serious adverse reactions attributable to SMC drugs. Vomiting was the most commonly reported mild adverse event but was reported in less than 1% of treatments. The average cost of delivery was US$0.50 per child per month, but varied widely depending on the size of the health post. Limitations included the low rate of mortality, which limited our ability to detect an effect on this endpoint. CONCLUSIONS: SMC substantially reduced the incidence of outpatient cases of malaria and of severe malaria in children, but no difference in all-cause mortality was observed. Introduction of SMC was associated with an overall reduction in malaria incidence in untreated age groups. In many areas of Africa with seasonal malaria, there is a substantial burden in older children that could be prevented by SMC. SMC in older children is well tolerated and effective and can contribute to reducing malaria transmission. TRIAL REGISTRATION: ClinicalTrials.gov NCT00712374.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Studies that integrated health facility-based interventions with community outreach often used mixed-setting clusters (33–36, 38, 48, 54, 61, 67, 72, 76, 78, 80, 92, 99, 103, 106–108).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Many of the interventions involved distributing and administering pharmaceutical treatments to prevent or manage diseases (28, 34, 36, 38–40, 42, 61, 90, 91, 93, 96, 98).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
The cited source says what the claim attributes to it.
In the citing paper
“Studies such as those by Calum Davey (35) and Badara Cisse (34) illustrate the value of accounting for temporal trends to reduce bias, aligning with guidance on SWD's analytical strengths (117).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [34]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The stepped wedge trial design: a systematic review
Brown, C. A., & Lilford, R. J. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-54 · Cited by 907
Cissé, B., Sokhna, C., Boulanger, D., Milet, J., Bâ, E. H., Richardson, K., Hallett, R., Sutherland, C., Simondon, K., Simondon, F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68264-0 · Cited by 209 · cited 1×
“Stepped-Wedge Design SMC (then known as intermittent preventive treatment in children [IPTc]) had been shown prior to the planning of this study to be highly effective in clinical trials [10,11], but it was questioned whether the intervention could be delivered on a large scale at reasonable cost, whether it would be…”
MethodCairns, M., Roca-Feltrer, A., Garske, T., Wilson, A. L., Diallo, D., Milligan, P. J., Ghani, A. C., & Greenwood, B. M. (2012) · Nature Communications · doi:10.1038/ncomms1879 · Cited by 186 · cited 1×
“1 cases per child per year, areas where SMC is likely to be most cost effective [2,3].”
BackgroundOkiro, E. A., Al-Taiar, A., Reyburn, H., Idro, R., Berkley, J. A., & Snow, R. W. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-4 · Cited by 153 · cited 1×
“In some parts of the areas suitable for SMC, the proportional burden of malaria in older children is increasing [7], reflecting slower acquisition of natural immunity; in these areas, Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten”
BackgroundHemming, K., & Girling, A. (2014) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1401400208 · Cited by 127
Sokhna, C., Cissé, B., Bâ, E. H., Milligan, P., Hallett, R., Sutherland, C., Gaye, O., Boulanger, D., Simondon, K., Simondon, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001471 · Cited by 99
NDiaye, J. L., Cissé, B., Ba, E. H., Gomis, J. F., Ndour, C. T., Molez, J. F., Fall, F. B., Sokhna, C., Faye, B., Kouevijdin, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162563 · Cited by 60
Self-citationNew Malaria-Control Policies and Child Mortality in Senegal: Reaching Millennium Development Goal 4
Trape, J.-F., Sauvage, C., Ndiaye, O., Douillot, L., Marra, A., Diallo, A., Cisse, B., Greenwood, B., Milligan, P., Sokhna, C., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir805 · Cited by 36
Noor, A. M., Kibuchi, E., Mitto, B., Coulibaly, D. M., Doumbo, O. K., & Snow, R. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136919 · Cited by 36
Lô, A. C., Faye, B. T., Bâ, E. H., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-137 · Cited by 27 · cited 3×
“falciparum infection at the end of the transmission season were more likely to carry the pfmdr1 86Y mutation associated with AQ resistance if they came from areas where SMC had been implemented [14], but the effect of this on the spread of resistance may be mitigated to some extent by the much lower prevalence of infe…”
BackgroundInfluential
Cited by
White, N. J. (2018) · Malaria Journal · doi:10.1186/s12936-018-2509-9 · Cited by 563
Ashley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research
Handley, M. A., Lyles, C. R., McCulloch, C., & Cattamanchi, A. (2018) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040617-014128 · Cited by 428
“…to implementation processes that could impact interpretation of findings such as academic vs community affiliation, urban vs rural (bed size) Cissé et al 2016 Randomized stepped wedge cluster trial Seasonal malaria prophylaxis for children up to age 10 in central Senegal given to households…”
BackgroundAntimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Baba, E., Hamade, P., Kivumbi, H., Marasciulo, M., Maxwell, K., Moroso, D., Roca-Feltrer, A., Sanogo, A., Stenstrom Johansson, J., Tibenderana, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32227-3 · Cited by 244
Prevention Efforts for Malaria
Tizifa, T. A., Kabaghe, A. N., McCann, R. S., van den Berg, H., Van Vugt, M., & Phiri, K. S. (2018) · Current Tropical Medicine Reports · doi:10.1007/s40475-018-0133-y · Cited by 192
The emergence of artemisinin partial resistance in Africa: how do we respond?
Rosenthal, P. J., Asua, V., Bailey, J. A., Conrad, M. D., Ishengoma, D. S., Kamya, M. R., Rasmussen, C., Tadesse, F. G., Uwimana, A., & Fidock, D. A. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00141-5 · Cited by 180
Li, J., Docile, H. J., Fisher, D. P., Pronyuk, K., & Zhao, L. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00228-2 · Cited by 212
“A cross-sectional assessment conducted in the North Region of Cameroon also supports a significant link of age have shown satisfactory results in multiple malaria-prone areas [ 31, 32 ].”
BackgroundCohee, L. M., Opondo, C., Clarke, S. E., Halliday, K. E., Cano, J., Shipper, A. G., Barger-Kamate, B., DJIMDÉ, A. A., Diarra, S., Dokras, A., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30325-9 · Cited by 180
Dicko, A., Roh, M. E., Diawara, H., Mahamar, A., Soumaré, H. M., Lanke, K. H. W., Bradley, J., Sanogo, K., Kone, D. T., Diarra, K., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30044-6 · Cited by 121
“Transmission reduction by seasonal malaria chemo-prevention could be further improved by expanding the age range to include adolescents because gametocyte carriage is high in this population 25,26 as observed by the age group enrolled in our study.”
BackgroundDruetz, T., Corneau-Tremblay, N., Millogo, T., Kouanda, S., Ly, A., Bicaba, A., & Haddad, S. H. S. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0599 · Cited by 100
Treatment and prevention of malaria in children
Ashley, E. A., & Poespoprodjo, J. R. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30127-9 · Cited by 108
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda
Asua, V., Vinden, J., Conrad, M. D., Legac, J., Kigozi, S. P., Kamya, M. R., Dorsey, G., Nsobya, S. L., & Rosenthal, P. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01818-18 · Cited by 76
“amodiaquine appears to be efficacious for malaria chemoprevention in areas where the pfdhps 540E mutation is absent (4), this regimen is unlikely to be effective in Uganda.”
BackgroundInfluentialSelvaraj, P., Wenger, E. A., & Gerardin, J. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3319-y · Cited by 87
Makenga, G., Menon, S., Baraka, V., Minja, D. T. R., Nakato, S., Delgado-Ratto, C., Francis, F. T., Lusingu, J., & Geertruyden, J. V. (2020) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2020.e00188 · Cited by 66
Near-term climate change impacts on sub-national malaria transmission
Lubinda, J., Haque, U., Bi, Y., Hamainza, B., & Moore, A. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-80432-9 · Cited by 70
Ndiaye, J. L., Ndiaye, Y., Bâ, M., Faye, B., Ndiaye, M., Seck, A. M., Tine, R. C. K., Thior, M., Atwal, S., Beshir, K. B., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002762 · Cited by 70
Clarke, S. E., Rouhani, S., Diarra, S., Saye, R., Bamadio, M., Jones, R., Traoré, D., Traoré, K., Jukes, M., Thuilliez, J., et al. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2016-000182 · Cited by 72
NDiaye, J. L., Cissé, B., Ba, E. H., Gomis, J. F., Ndour, C. T., Molez, J. F., Fall, F. B., Sokhna, C., Faye, B., Kouevijdin, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162563 · Cited by 60
Self-citationStaedke, S. G., Maiteki‐Sebuguzi, C., Rehman, A. M., Kigozi, S. P., Gonahasa, S., Okiring, J., Lindsay, S. W., Kamya, M. R., Chandler, C., Dorsey, G., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30126-8 · Cited by 64
“25 The results from our trial contribute to the growing body of evidence of the effectiveness of IPT for malaria in older children, 7–10 and suggest that reducing the infectious reservoir could have positive effects on the surrounding community.”
ResultCairns, M. E., Sagara, I., Zongo, I., Kuepfer, I., Théra, I., Nikièma, F., Diarra, M., Yerbanga, R. S., Barry, A., Tapily, A., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003214 · Cited by 56
“Low specificity is likely to be a consequence of parasite antigens remaining in the circulation of children whose infection has been cleared by SMC or treatment, as observed in a previous SMC study in Senegal [6].”
BackgroundKonate, D. S., Diawara, S. I., Touré, M., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-03202-y · Cited by 51
Bâ, E. H., Pitt, C., Dial, Y., Faye, S. L., Cairns, M. E., Faye, E., Ndiaye, M., Gomis, J. F., Faye, B., Ndiaye, J. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23878-2 · Cited by 60
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
Greenwood, B. M., Dicko, A., Sagara, I., Zongo, I., Tinto, H., Cairns, M. E., Kuepfer, I., Milligan, P. J., Ouédraogo, J., Doumbo, O. K., et al. (2017) · Malaria Journal · doi:10.1186/s12936-017-1841-9 · Cited by 49
“An increase in the proportion of malaria parasites carrying markers of resistance to SP at the end of the malaria transmission season was recorded in some of the initial trials of SMC [2, 7] and, although there is currently no evidence that SMC is failing because of the emergence of resistance, this is a potential thr…”
BackgroundWagman, J., Gogue, C., Tynuv, K., Mihigo, J., Bankineza, E., Bah, M., Diallo, D. A., Saibu, A., Richardson, J. H., Kone, D., et al. (2018) · Malaria Journal · doi:10.1186/s12936-017-2168-2 · Cited by 51
Issiaka, D., Barry, A., Traore, T., Diarra, B., Cook, D., Keïta, M., Sagara, I., Duffy, P. E., Fried, M., & Dicko, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03175-y · Cited by 46
“did not find a difference in mortality between SMC and non-SMC areas [10].”
BackgroundResultBarry, A., Issiaka, D., Traore, T., Mahamar, A., Diarra, B., Sagara, I., Koné, D., Doumbo, O. K., Duffy, P. E., Fried, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193296 · Cited by 46
“Coverage of individual rounds of SMC varied between 84% and 89% in children who received SMC, with 76% of children who received all three rounds of SMC using DDD method while a consistently greater than 80% coverage over three years was reported in a large stepwise study in Senegal [16]. https://doi.org/10.1371/journa…”
BackgroundMethodInfluentialMalaria: How Are We Doing and How Can We Do Better?
Rosenthal, P. J., John, C. C., & Rabinovich, N. R. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0997 · Cited by 51
Ding, J., Coldiron, M. E., Assao, B., Guindo, O., Blessborn, D., Winterberg, M., Grais, R. F., Koščálová, A., Langendorf, C., & Tärning, J. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1707 · Cited by 39
“SMC has also been shown to reduce the prevalence of asymptomatic parasitemia at the end of the transmission season.(15) In conjunction with the Ministry of Public Health of Niger, Médecins Sans Frontières began implementing SMC in the Magaria District of Niger in 2013.”
BackgroundMalaria in Cambodia: A Retrospective Analysis of a Changing Epidemiology 2006–2019
Chhim, S., Piola, P., Housen, T., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041960 · Cited by 39
Makenga, G., Baraka, V., Francis, F. T., Minja, D. T. R., Gesase, S., Kyaruzi, E. S., Mtove, G. A., Nakato, S., Madebe, R. A., Søeborg, S. R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268654 · Cited by 40
“The shift in malaria epidemiology has been attributed to increased interventions that formerly left out schoolchildren and some included children aged under ten years [65,66,69].”
BackgroundTripura, R., von Seidlein, L., Sovannaroth, S., Peto, T. J., Callery, J. J., Sokha, M., Ean, M., Heng, C., Conradis-Jansen, F., Madmanee, W., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00492-3 · Cited by 41
Cheng, N. I., Okyere, D., Enos, J. Y., Mensah, B. A., Nyarko, A. K., Abuaku, B. K., Amambua‐Ngwa, A., Merle, C. S., Koram, K. A., & Ahorlu, C. (2019) · BMC Public Health · doi:10.1186/s12889-019-7986-4 · Cited by 36
Kirakoya‐Samadoulougou, F., Brouwere, V. D., Fokam, A. F., Ouédraogo, M., & Yé, Y. (2022) · Malaria Journal · doi:10.1186/s12936-022-04172-z · Cited by 41
“According to research, repeated cycles of SMC could contribute to reduce overall malaria transmission [32].”
BackgroundMoukenet, A., de Cola, M. A., Ward, C., et al. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01684-7 · Cited by 34
“In addition, Chad is assessing the feasibility of expanding SMC at scale, both to new areas of the country and to school age children as in other similar settings [21, 22].”
BackgroundSystematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention
Thwing, J. I., Williamson, J. M., Cavros, I., & Gutman, J. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0481 · Cited by 43
“25,29 Two studies from Senegal 22,26 reported a prevalence of severe anemia (hemoglobin , 5g/dL), but the extremely low prevalence resulted in wide CIs and nonsigni fi cant reductions.”
BackgroundMethodInfluentialKesteman, T., Randrianarivelojosia, M., & Rogier, C. (2017) · F1000Research · doi:10.12688/f1000research.12952.1 · Cited by 35
Nuwa, A., Baker, K. S., Bonnington, C. A., Odongo, M., Kyagulanyi, T., Bwanika, J. B., Richardson, S., Nabakooza, J., Achan, J., Kajubi, R., et al. (2023) · Malaria Journal · doi:10.1186/s12936-023-04488-4 · Cited by 37
Yaro, J. B., Tiono, A. B., Ouédraogo, A., Lambert, B. C., Ouedraogo, Z. A., Diarra, A., Traoré, A., Lankouande, M., Soulama, I., Sanou, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05056-7 · Cited by 33
A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria
Burrows, J. N., Slater, H., Macintyre, F., Rees, S., Thomas, A., Okumu, F. O., van Huijsduijnen, R. H., Duparc, S., & Wells, T. N. C. (2018) · Malaria Journal · doi:10.1186/s12936-018-2598-5 · Cited by 28
Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations
Ndiaye, Y. D., Hartl, D. L., McGregor, D., Badiane, A. S., Fall, F. B., Daniels, R. F., Wirth, D. F., Ndiaye, D., & Volkman, S. K. (2021) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2021.07.004 · Cited by 30
“SMC may reduce the incidence in untreated age groups (Cisse et al., 2016), suggesting an interruption of”
BackgroundMahamar, A., Sumner, K. M., Levitt, B. E., Freedman, E., Traoré, A., Barry, A., Issiaka, D., Dembele, A. B., Kanoute, M. B., Attaher, O., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04059-z · Cited by 27
“In Senegal, a study indicated that the overall proportion of children carrying parasites with these mutations was lower in SMC areas than in areas where SMC had not been implemented [24].”
BackgroundPitt, C., Ndiaye, M., Conteh, L., Sy, O., Bâ, E. H., Cissé, B., Gomis, J. F., Gaye, O., Ndiaye, J. L., & Milligan, P. J. (2017) · Health Policy and Planning · doi:10.1093/heapol/czx084 · Cited by 32
“In the implementation area, 32% of the population was under 10 years old (Cisse et al. 2016).”
InfluentialTabue, R. N., Njeambosay, B., Zeukeng, F., Esemu, L. F., Fodjo, B. A. Y., Nyonglema, P., Awono‐Ambene, P., Etang, J., Fondjo, É., Achu, D., et al. (2019) · BioMed Research International · doi:10.1155/2019/9709013 · Cited by 28
“Therefore, there is a need to expand prevention strategies such as SMC to school-age children [35, 36] to cover the peak transmission months in order to impact more the disease burden.”
BackgroundSchool-based screening and treatment may reduce P. falciparum transmission
Cohee, L. M., Valim, C., Coalson, J. E., Nyambalo, A., Chilombe, M. B., Ngwira, A., Bauleni, A., Seydel, K. B., Wilson, M. L., Taylor, T. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86450-5 · Cited by 25
Multilevel modelling of the risk of malaria among children aged under five years in Nigeria
Oguoma, V. M., Anyasodor, A. E., Adeleye, A. O., Eneanya, O. A., & Mbanefo, E. C. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa092 · Cited by 29
“In fact, a seasonal malaria chemoprevention program has been piloted, and shown to signi cantly reduce malaria in under 5 children participating in the mass drug administration program in different areas of diverse malaria transmission intensity (14-17).”
BackgroundNikiema, S., Soulama, I., Sombié, S., Tchouatieu, A.-M., Sermé, S. S., Henry, N. B., Ouédraogo, N., Ouaré, N., Ily, R., Ouédraogo, O., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s375197 · Cited by 24
“Senegal is a pilot country in extending the age target from 5 to 10 years.(15,19) Confirmation of the interest of the extension of the age range is strongly awaited to further enlighten the scientific community on the cost-benefit of this extension.”
BackgroundFrancica, J. R., Shi, W., Chuang, G., Chen, S. J., Pereira, L. D. S., Farney, S. K., Flynn, B. J., Ou, L., Stephens, T., Tsybovsky, Y., et al. (2021) · Vaccines · doi:10.3390/vaccines9030272 · Cited by 22
Spatio-temporal variation of malaria hotspots in Central Senegal, 2008–2012
Dieng, S., Bâ, E. H., Cissé, B., Sallah, K., Guindo, A., Ouédraogo, B., Piarroux, M., Rebaudet, S., Piarroux, R., Landier, J., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05145-w · Cited by 30
Bakaï, T. A., Thomas, A., Iwaz, J., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04434-w · Cited by 21
“Several other studies carried out in Africa have also demonstrated that SMC was well tolerated and helped reducing malaria transmission [13, 14].”
ResultMalaria 2017: Update on the Clinical Literature and Management
Daily, J. P. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0583-8 · Cited by 25
Burgert, L., Reiker, T., Golumbeanu, M., Möhrle, J. J., & Penny, M. A. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000211 · Cited by 22
“Operational constraints result in reduced coverage over the number of rounds [5,6] and adherence [11], thus hindering SMC-SP+AQ from reaching its full potential.”
BackgroundR Adjei, M., Kubio, C., Buamah, M., Sarfo, A., Suuri, T., Ibrahim, S., Sadiq, A., I Abubakari, I., & V Baafi, J. (2022) · Ghana Medical Journal · doi:10.4314/gmj.v56i2.2 · Cited by 20
“However, while our study observed a 17% drop in morbidity, reductions between 30% and 60% have been reported.(12,13,14) In addition, much higher reductions in the episodes of severe malaria were observed in separate studies by Diawara et al (2019) and Cisse et al (2016) compared to what was observed in this study (62%…”
ResultWagman, J., Cissé, I., Kone, D., Fomba, S., Eckert, E. L., Mihigo, J., Bankineza, E., Bah, M., Diallo, D. A., Gogue, C., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-03361-y · Cited by 18
Eichner, F. A., Groenwold, R. H. H., Grobbee, D. E., & Rengerink, K. O. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.11.013 · Cited by 22
Moukenet, A., Donovan, L., Honoré, B., Baker, K., Smith, H., Richardson, S., & Ward, C. (2022) · Global Health Science and Practice · doi:10.9745/ghsp-d-21-00161 · Cited by 18
“Based on surveillance data showing the burden of malaria in older children, trials conducted in Senegal indicate extending SMC to children aged younger than 10 years is effective, acceptable, and could contribute to reducing malaria transmission and thus have a greater impact on malaria burden.(21,22) In addition, rec…”
BackgroundResultMaccario, R., Rouhani, S., Drake, T., Nagy, A., Bamadio, M., Diarra, S., Djanken, S., Roschnik, N., Clarke, S. E., Sacko, M., et al. (2017) · BMC Public Health · doi:10.1186/s12889-017-4490-6 · Cited by 22
“Better understanding the financial and economic costs of schoolbased interventions will help to inform ongoing questions of whether malaria control programmes can be channelled through schools, particularly in light of the availability of new preventive strategies such as seasonal malaria chemoprevention [14, 15], and…”
BackgroundRehman, A. M., Maiteki‐Sebuguzi, C., Gonahasa, S., Okiring, J., Kigozi, S. P., Chandler, C., DRAKELEY, C. J., Dorsey, G., Kamya, M. R., & Staedke, S. G. (2019) · Malaria Journal · doi:10.1186/s12936-019-2954-0 · Cited by 18
Maiga, H., Gaudart, J., Sagara, I., Diarra, M., Bamadio, A., Djimdé, M., Coumaré, S., Sangare, B., Dicko, Y., Tembély, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186639 · Cited by 19
Konate, D. S., Diawara, S. I., Keïta, B., et al. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0046 · Cited by 17
“6,24,25 Comparing the cumulative incidence of P. falciparum parasitemia from July to December (period of intense transmission), SMC likely averted 34.70% of new P. falciparum parasitemia infections in children who received SP and AQ.”
InfluentialBottieau, E., Mbow, M., Brosius, I., Roucher, C., Gueye, C. T., Mbodj, O. T., Faye, B. T., Hondt, A. D., Smekens, B., Arango, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02719-4 · Cited by 18
Elliott, R. C., Smith, D. L., & Echodu, D. C. (2019) · Malaria Journal · doi:10.1186/s12936-019-2788-9 · Cited by 17
Seasonal malaria chemoprevention: closing the know–do gap
Ashley, E. A., & Yeka, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32525-3 · Cited by 16
Richardson, S., Moukenet, A., Diar, M. S. I., et al. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0314 · Cited by 16
“A metaanalysis of SMC studies with monthly administration of SPAQ to children aged less than five years during the peak malaria transmission season showed an 83% (95% CI: 72–89) reduction in the incidence of clinical attacks of malaria and a similar reduction in incidence of severe malaria.13 Among these studies, a tr…”
BackgroundInfluentialMaximizing Impact: Can Interventions to Prevent Clinical Malaria Reduce Parasite Transmission?
McCann, R. S., Cohee, L. M., Goupeyou-Youmsi, J., & Laufer, M. K. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.07.013 · Cited by 15
Wharton–Smith, A., Baker, K. S., Roca‐Feltrer, A., Rodrigues, M., Richardson, S., Bonnington, C. A., Rassi, C., Marasciulo, M., Enosse, S. M., Saúte, F., et al. (2021) · JMIR Research Protocols · doi:10.2196/27855 · Cited by 13
Rogier, E. W., Herman, C., Huber, C. S., Hamre, K. E. S., Pierre, B., Mace, K. E., Présumé, J., Mondélus, G., Romilus, I., Elismé, T., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2605.190556 · Cited by 16
“These attributes have made SP an attractive option for malaria chemoprophylaxis (9,12) and other types of populationbased mass drug administration (MDA) campaigns (13).”
BackgroundRichardson, S., Ibinaiye, T., Nikau, J. I., Oresanya, O. B., Marasciulo, M., Roca‐Feltrer, A., Rassi, C., & Adesoro, O. (2020) · Tropical Medicine and Health · doi:10.1186/s41182-020-00288-7 · Cited by 15
Dieng, S., Michel, P., Guindo, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114168 · Cited by 12
“The data used for this study were collected between January 2008 and December 2012 during a field trial of Seasonal Malaria Chemoprevention (SMC) among children from 575 villages in westcentral Senegal [23,24].”
BackgroundMethodInfluentialKonate, D. S., Diawara, S. I., Sogoba, N., et al. (2023) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2022.e00283 · Cited by 12
Sacko, A., Sagara, I., Berthé, I., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020840 · Cited by 12
“This strategy consists of administering a single dose of SP and a dose of Amodiaquine for three days, in four rounds, to children aged 3–59 months and, recently, 5 to 10 years old [10,11].”
MethodPrevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
Coldiron, M. E., Assao, B., Guindo, O., Sayinzoga-Makombe, N., Koščálová, A., Sterk, E., Quere, M., Ciglenečki, I., Mumina, A., Atti, S., et al. (2021) · Malaria Journal · doi:10.1186/s12936-021-03953-2 · Cited by 14
Household-level effects of seasonal malaria chemoprevention in the Gambia
Soremekun, S., Conteh, B., Nyassi, A., Soumaré, H. M., Etoketim, B. N., Ndiath, M. O., Bradley, J., D’Alessandro, U., Bousema, T., Erhart, A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00503-0 · Cited by 11
“Thissuggests extended-ageSMC,besidesreducingclinicalillnessindirectrecipients,may havewiderimpactsontransmissiontonon-recipients 6,17,18 .”
Ahmad, A., Prom, A., Bradley, J., Ndiath, M. O., Etoketim, B. N., Bah, M., Geertruyden, J. V., DRAKELEY, C. J., Bousema, T., Achan, J., et al. (2021) · Malaria Journal · doi:10.1186/s12936-021-03706-1 · Cited by 12
Sy, O., Sarr, P. C., Assogba, B. S., Ndiaye, M., Dia, A. K., Ndiaye, A., Nourdine, M. A., Gueye, O. K., Konaté, L., Gaye, O., et al. (2021) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2021.104783 · Cited by 12
“…qPCR, quantitative polymerase chain reaction; ATL, Animal Tissue Lysis; Buffer ATL, is a tissue lysis buffer for use in purification of nucleic acids. under-ten was highly effective in reducing the malaria burden among young and old children by at least 60% (Cisse et al., 2016).”
BackgroundIbinaiye, T., Oresanya, O. B., Oguoma, C., Aidenagbon, A., Ogunmola, O., Rassi, C., & Richardson, S. (2023) · Malaria Journal · doi:10.1186/s12936-023-04576-5 · Cited by 15
“In a study conducted in Senegal [15], Cissé and Sokhna identified parental socioeconomic background and perceived knowledge of potential adverse events arising from administration of AQ on Day 2 and Day 3 as part of SMC as predictors of non-adherence to full the full course of SP and AQ among children aged under 10 ye…”
BackgroundResultInfluentialKinyoki, D. K., Moloney, G. M., Uthman, O. A., Odundo, E. O., Kandala, N., Noor, A. M., Snow, R. W., & Berkley, J. A. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0449-9 · Cited by 11
Tairou, F., Diallo, A., Sy, O., Koné, A., Manga, I. A., Sylla, K., Lélo, S., Fall, C. B., Sow, D., Ndiaye, M., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04212-8 · Cited by 19
“Seasonal malaria chemoprevention and reactive case detection have recently been introduced in specific geographic areas in Senegal [6, 7].”
BackgroundMahamar, A., Issiaka, D., Youssouf, A., et al. (2021) · Malaria Journal · doi:10.1186/s12936-020-03542-9 · Cited by 10
“In Senegal, SMC was associated with reduction in transmission as shown by a reduced incidence of confirmed malaria in children and adults above the age for SMC, who did not receive SMC in the areas where SMC was used compared to those in the area where it is not [17].”
MethodMorlino, C., Byrne, I., Achan, J., Baraka, V., Barry, A., Bousema, T., Camara, A., Chacky, F., Chico, R. M., Clarke, S. E., et al. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1480907 · Cited by 11
Boyce, R. M., Hollingsworth, B., Baguma, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab781 · Cited by 9
“implemented among school-aged children [41-43].”
Sondo, P., Tahita, M. C., Ilboudo, H., et al. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00800-x · Cited by 9
“which showed promising results in Senegal [13].”
InfluentialSy, O., Sarr, P. C., Assogba, B. S., Nourdine, M. A., Ndiaye, A., Konaté, L., Faye, O., Donnelly, M. J., Gaye, O., Weetman, D., et al. (2023) · Journal of Medical Entomology · doi:10.1093/jme/tjad020 · Cited by 10
Biggs, J. R., Challenger, J. D., Hellewell, J., Churcher, T. S., & Cook, J. A. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02361-9 · Cited by 11
Kambou, S. A. E., Millogo, K. S., Sondo, P., Kaboré, B., Kouevi, A. F. C., Bouda, I., Rouamba, T., Derra, K., Tahita, M. C., Ilboudo, H., et al. (2024) · Parasitology Research · doi:10.1007/s00436-024-08380-1 · Cited by 10
Manga, I. A., Tairou, F., Seck, A. M., Kouevidjin, E., Sylla, K., Sow, D., Gueye, A. B., Bâ, M., Ndiaye, M., Tine, R. C. K., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18057.3 · Cited by 8
“This very good efficiency of the SMC around 90%, had already been demonstrated in many studies conducted in the research context 8 .”
Bisanzio, D., Keita, M. S., Camara, A., Guilavogui, T., Diallo, T., Barry, H., Preston, A., Bangoura, L., Mbounga, E., Florey, L., et al. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2023-013898 · Cited by 11
Afolabi, M. O., Sow, D., Ndiaye, J. L., & Greenwood, B. M. (2022) · Trials · doi:10.1186/s13063-022-06579-0 · Cited by 9
“Setting up of surveillance teams A surveillance system will be established with the health centres and health posts in the study areas, before the start of the malaria transmission period, to detect and record adverse reactions and adverse events that may be related to SMC and anthelminthic drugs as implemented succes…”
BackgroundInfluentialIntegrating vulnerability and hazard in malaria risk mapping: the elimination context of Senegal
Morlighem, C., Nnanatu, C. C., Aheto, J. M. K., & Linard, C. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11412-5 · Cited by 7
“A new epidemiological profile is emerging in the northern regions, with hotspots of residual transmission [9, 65, 72, 73].”
Lee, K. M., Ma, X., Yang, G. M., & Cheung, Y. B. (2022) · Statistics in Medicine · doi:10.1002/sim.9394 · Cited by 9
Ratio estimators of intervention effects on event rates in cluster randomized trials
Ma, X., Milligan, P. J., Lam, K. F., & Cheung, Y. B. (2021) · Statistics in Medicine · doi:10.1002/sim.9226 · Cited by 7
Kazanga, B., Bâ, E. H., Legendre, E., Cissoko, M., Fleury, L., Bérard, L., Diop, A., Sokhna, C., Danfakha, F., Sagara, I., et al. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003197 · Cited by 12
Baker, K. S., Tarquino, I. A. P., Aíde, P., et al. (2025) · Malaria Journal · doi:10.1186/s12936-024-05229-x · Cited by 6
“Large scale clinical trials administering SP + AQ as SMC [20–22] have shown significant protective effectiveness against clinical malaria during the transmission season.”
Somé, A. F., Bazié, T., Ehrlich, H. Y., Goodwin, J., Lehane, Á., Neya, C., Kabré, Z., Wade, M., Ouattara, J.-M., Foy, B. D., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-03311-8 · Cited by 6
Ahorlu, C., Cheng, N. I., Okyere, D., Mensah, B. A., Chu, C. E., Enos, J. Y., & Abuaku, B. K. (2022) · Pathogens · doi:10.3390/pathogens11101118 · Cited by 7
Ouoba, J., Lankoandé-Haro, S., Fofana, S., et al. (2023) · Santé Publique · doi:10.3917/spub.235.0121 · Cited by 6
Sallah, K., Giorgi, R., Bâ, E. H., Piarroux, M., Piarroux, R., Griffiths, K., Cissé, B., & Gaudart, J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/403626 · Cited by 6
Diarra, K., Dembele, B., Ouattara, A., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-22461-5 · Cited by 5
“In Senegal, the same result was noted by Badara CISSE and al in the study of the effectiveness of seasonal malaria chemoprevention in children under ten years of age, more than 80% [18].”
Kulohoma, B. W., & Wesonga, C. S. A. (2026) · npj Women s Health · doi:10.1038/s44294-025-00124-5 · Cited by 11
“These children represent an important reservoir for human-to-mosquito parasite transmission prompting suggestions for seasonal malaria chemoprevention to reduce malaria incidence in this population 66,68,69 .”
Arzika, A. M., Maliki, R., Amza, A., Karamba, A. M., Galo, N., Aichatou, B., Sara, I. I., Beidi, D., Haroun, L. M., Oumarou, F., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002559 · Cited by 6
Metadata
- Authors
- Cissé, B., Ba, E. H., Sokhna, C., NDiaye, J. L., Gomis, J. F., Dial, Y., Pitt, C., NDiaye, M., Cairns, M., Faye, E., NDiaye, M., Lo, A., Tine, R., Faye, S., Faye, B., Sy, O., Konate, L., Kouevijdin, E., Flach, C., Faye, O., Trape, J.-F., Sutherland, C., Fall, F. B., Thior, P. M., Faye, O. K., Greenwood, B., Gaye, O., & Milligan, P.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Institut de Recherche pour le Développement (SN)
- Cheikh Anta Diop University (SN)
- Corresponding author
- Milligan, Paul
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-22
- Volume
- 13
- Issue
- 11
- Pages
- e1002175
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5119693
- OpenAlex
- W2549904414
- Semantic Scholar
- e6a098bdd1abc4b8af46ccccb9f99306619a22fa
- Cited by
- 191
- References
- 10
- Citations by year
- 2026: 23 · 2025: 21 · 2024: 22 · 2023: 15 · 2022: 24 · 2021: 25 · 2020: 23 · 2019: 10 · 2018: 17 · 2017: 9 · 2016: 2
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (40099)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- seasonal malaria chemoprevention, sulfadoxine-pyrimethamine, amodiaquine, malaria mortality, parasitemia, anemia, drug resistance, insecticide-treated nets, adverse drug reactions, community attitudes, Senegal
- MeSH terms
- Amodiaquine, Antimalarials, Child, Child, Preschool, Drug Combinations, Humans, Infant, Malaria, Pyrimethamine, Seasons, Senegal, Sulfadoxine, Chemoprevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.